A phase Ib study of abemaciclib with therapies for metastatic breast cancer.

被引：9

作者：

Tolaney, Sara M.

Beeram, Muralidhar

Beck, J. Thaddeus

Conlin, Alison Katherine

Dees, Elizabeth Claire

Dickler, Maura N.

Helsten, Teresa L.

Conkling, Paul R.

Edenfield, William Jeffery

Richards, Donald A.

Turner, P. Kellie

Cai, Na

Chan, Edward Michael

Pant, Shubham

Becerra, Carlos

Kalinsky, Kevin

Puhalla, Shannon

Rexer, Brent Neil

Burris, Howard A.

Goetz, Matthew P.

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] START Ctr Canc Care, San Antonio, TX USA

[3] Highlands Oncol Grp, Fayetteville, AR USA

[4] Providence Canc Ctr, Oncol & Hematol Care Clin, Portland, OR USA

[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[7] Univ Calif San Diego, La Jolla, CA USA

[8] Virginia Oncol Associates, Norfolk, VA USA

[9] ITOR Greenville Hosp Syst, Clin Res Unit, Greenville, SC USA

[10] Texas Oncol Tyler, Tyler, TX USA

[11] Eli Lilly & Co, Indianapolis, IN 46285 USA

[12] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA

[13] Texas Oncol Baylor Sammons Canc Ctr, Dallas, TX USA

[14] Columbia Univ, Med Ctr, New York, NY USA

[15] Univ Pittsburgh, Med Ctr, Womens Canc Program, Magee Womens Hosp UMPC, Pittsburgh, PA USA

[16] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[17] Sarah Cannon Res Inst SCRI, Nashville, TN USA

[18] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.522

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

522

引用

页数：1

共 50 条

[21] Phase I/II study of carboplatin, vinorelbine and capecitabine in metastatic breast cancer.
Rabinowitz, MJ
Mangalik, A
Lee, FC
Cathcart, C
Verschraegen, C
Rabinowitz, I
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 57S - 57S
[22] MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease
Jung, Kyung Hae
Im, Seock-Ah
Yardley, Denise
Hurvitz, Sara
Lee, Keun Seok
Sonnenblick, Amir
Shachar, Shlomit
Tan, Antoinette
Comen, Elizabeth
Gal-Yam, Einav
Brufsky, Adam
Rugo, Hope
Zhu, Jing
DuPree, Kelly
Breton, Vanessa
Young, Fiona
Schwab, Richard
Cha, Edward
Telli, Melinda
CANCER RESEARCH, 2024, 84 (09)
[23] ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.
Leone, Jose Pablo
Ruddy, Kathryn Jean
Rashid, Naim
Giordano, Sharon H.
Gupta, Gaorav P.
Hilsenbeck, Susan G.
Gucalp, Ayca
Walsh, Elaine M.
Sukumar, Jasmine S.
Makhlin, Igor
Ortiz-Perez, Tamara
Spanheimer, Philip Merle
Calhoun, Benjamin C.
Wolff, Antonio C.
Krop, Ian E.
Thompson, Alastair Mark
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[24] Phase Ib study of stereotactic radiation and nivolumab in the management of metastatic breast cancer with brain metastases
Ahmed, Kamran A.
Kim, Youngchul
Armaghani, Avan J.
Arrington, John A.
Caudell, Jimmy J.
Costa, Ricardo L.
Czerniecki, Brian J.
Etame, Arnold B.
Forsyth, Peter A.
Khong, Hung T.
Kim, Sungjune
Loftus, Loretta
Robinson, Timothy J.
Rosa, Marilin
Sahebjam, Solmaz
Soliman, Hatem H.
Soyano, Aixa E.
Tran, Nam D.
Yu, H. Michael
Han, Hyo S.
CANCER RESEARCH, 2020, 80 (04)
[25] A phase IB study of Tarceva™ (erlotinib) plus capecitabine and docetaxel in metastatic breast cancer (MBC).
Trigo, J
Baselga, J
De Rosa, F
Brennscheidt, U
Rakhit, A
Fettner, S
Jones, R
Wright, T
Twelves, C
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6087S - 6087S
[26] Phase Ib study of ixabepilone (I) in combination with epirubicin (E) in women with metastatic breast cancer
Roche, H. H.
Zambetti, M.
Dalenc, F.
Govi, S.
Gladieff, L.
Mudenda, B.
Lainas, I.
Iacono, L.
Gianni, L.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[27] A phase I/IB study of ipatasertib in combination with carboplatin or carboplatin/paclitaxel or capecitabine and atezolizumab in patients with metastatic triple-negative breast cancer.
Yuan, Yuan
Yost, Susan Elaine
Frankel, Paul Henry
Ruel, Christopher
Murga, Mireya
Tang, Aileen
Martinez, Norma
Waisman, James Ross
Stewart, Daphne B.
Patel, Niki Himat
Mortimer, Joanne E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[28] SUCCESSIVE HORMONE THERAPIES IN BREAST-CANCER IN THE METASTATIC PHASE
MOUSSEAU, M
SWIERCZ, P
SCHAERER, R
BULLETIN DU CANCER, 1985, 72 (04) : 346 - 347
[29] A phase Ib study evaluating the safety and tolerability of durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer.
Landry, Chrystal Ann
Guziel, Jeannette Marcelle
Ru, Meng
Shapiro, Charles L.
Fasano, Julie
Bhardwaj, Aarti Sonia
Irie, Hanna
Bhardwaj, Nina
Tiersten, Amy
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[30] A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer
Schwartzberg, Lee S.
Yardley, Denise A.
Elias, Anthony D.
Patel, Manish
LoRusso, Patricia
Burris, Howard A.
Gucalp, Ayca
Peterson, Amy C.
Blaney, Martha E.
Steinberg, Joyce L.
Gibbons, Jacqueline A.
Traina, Tiffany A.
CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4046 - 4054

← 1 2 3 4 5 →